Monte Rosa Therapeutics (GLUE) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $2.1 million.
- Monte Rosa Therapeutics' Shares Outstanding fell 3623.81% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 3623.81%. This contributed to the annual value of $3.2 million for FY2024, which is 292.77% down from last year.
- Monte Rosa Therapeutics' Shares Outstanding amounted to $2.1 million in Q3 2025, which was down 3623.81% from $1.9 million recorded in Q2 2025.
- Over the past 5 years, Monte Rosa Therapeutics' Shares Outstanding peaked at $4.8 million during Q1 2023, and registered a low of $1.9 million during Q2 2025.
- In the last 3 years, Monte Rosa Therapeutics' Shares Outstanding had a median value of $3.3 million in 2024 and averaged $3.2 million.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Shares Outstanding soared by 194.11% in 2024, and later plummeted by 4314.82% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Shares Outstanding (Quarter) stood at $3.3 million in 2023, then decreased by 2.93% to $3.2 million in 2024, then crashed by 34.98% to $2.1 million in 2025.
- Its Shares Outstanding was $2.1 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.0 million in Q1 2025.